Hyperpolarized

Authors :: David G, Mummy
Elianna A, Bier
Ziyi, Wang
Jennifer, Korzekwinski
Lake, Morrison
Christina, Barkauskas
H Page, McAdams
Robert M, Tighe
Bastiaan, Driehuys
Joseph G, Mammarappallil
Source :: Radiology. 301(1)
Publication Year :: 2021
Abstract: Background Recent studies demonstrate that antifibrotic drugs previously reserved for idiopathic pulmonary fibrosis (IPF) may slow progression in other interstitial lung diseases (ILDs), creating an urgent need for tools that can sensitively assess disease activity, progression, and therapy response across ILDs. Hyperpolarized xenon 129 (